Company News
-
Latest Research on Steroids
Approval of Vamorolone Licensed by SinoMedica According to the public notice on the official website of the National Medical Products Administration of China, the marketing application for the oral suspension of the steroid drug Vamorolone submitted by SinoMedica has been approved. Vamoro...Read more -
Significant Breakthrough in Steroid Powder Research
Recently, the company has achieved a significant outcome in the research field of steroid powder. During this research, through in – depth improvements to the traditional preparation process, the scientific research personnel innovatively adopted a technical approach, ...Read more -
Company Expands Business Territory, Mult-Platform Strategy Launches in Full Swing
Today, the company officially announced the simultaneous launch of multiple business platforms under its umbrella. The aim is to provide users with a richer and more diverse service experience, further solidifying its leading position within the industry. The multiple platforms roll...Read more -
Frontier Bioproducts Land on the New Platform with a Bang
In the booming era of biotechnology, our company is proud to announce that hundreds of meticulously developed peptide, steroid and other bioproducts have been officially launched on Global Sources, injecting new vitality into the fields of healthcare, scientific research and more. T...Read more -
A New Journey of Green Development, Leading a New Future with Environmental Protection
In the current era when environmental protection has become a global focus, our company has always deeply embedded the concept of environmental protection into the very core of its corporate development. Through a series of innovative practices and proactive actions, it contributes to ...Read more -
Innovating and Leading, Embarking on a New Chapter in the Pharmaceutical and Chemical Industry
The company has been continuously delving deep into the pharmaceutical and chemical industry. Recently, it has become the focus of the industry by virtue of its outstanding innovative achievements and strategic layouts. The company’s R & D center has assembled a large nu...Read more -
Steroids: Versatile Players in the Pharmaceutical and Chemical Industry
In the field of pharmaceutical and chemical engineering, steroids are an extremely important class of compounds. Their chemical structure is based on a four-ring carbon skeleton, and this unique structure endows steroids with diverse biological activities and functions, making them key ...Read more -
Peptides and Pharmaceutical Chemistry: Closely Intertwined, Jointly Promoting Development
In recent years, the significance of peptides in the field of pharmaceutical chemistry has become increasingly prominent. The two are intertwined, bringing new opportunities and breakthroughs for the development of the pharmaceutical industry. In the medical field, peptides are ...Read more -
Initiating a New Era of Peptide Technology and Leading a New Future of Health
In the current era of booming biotechnology, our company, as a pioneering enterprise in the industry, is powerfully shaping a new pattern in the field of peptides with remarkable innovation achievements and far-reaching industry influence. Recently, our company’s research ...Read more -
Major Breakthrough: Global Product Launches with a Bang
In the continuously evolving global business scenario today, the company is delighted to announce the official launch of its elaborately developed global product. This milestone indicates a firm and crucial step in the company’s international strategic plan. The global produ...Read more -
Latest Research on Fitness Peptides
Studies on Components and Functions The research team of Guotai took cod skin as the raw material and adopted the “two-step” enzymatic hydrolysis technology with compound protease and flavor protease to prepare collagen peptides with a relatively high content of small molecular pepti...Read more -
Latest Research on Sarm Products
Research on Breast Cancer Treatment Enobosarm: A multicenter, open-label, randomized, parallel, phase II study demonstrated that for the treatment of ER+ advanced breast cancer with oral Sarm enobosarm, the clinical benefit rate in the 9mg group was 25.0% at 24 weeks, and that in the 18mg group...Read more